OFFER TO PURCHASE FOR CASH ANY OR ALL OF THE $44,412,500 AGGREGATE FACE VALUE (SUBJECT TO A $22,206,250 MINIMUM) OF CONTINGENT PAYMENT RIGHTS OF MEDAREX, INC. BY BCC ACQUISITION I LLCBCC Acquisition I LLC • June 19th, 1998 • Biological products, (no disgnostic substances)
THIS WARRANT AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED...Warrant And • June 19th, 1998 • BCC Acquisition I LLC • Biological products, (no disgnostic substances) • New Jersey
LLC OPERATING AGREEMENT FOR BCC ACQUISITION I LLCLLC Operating Agreement • June 19th, 1998 • BCC Acquisition I LLC • Biological products, (no disgnostic substances)
MEDAREX, INC. RIGHTS EXCHANGE AGREEMENT JUNE 10, 1998 TABLE OF CONTENTSAgreement • June 19th, 1998 • BCC Acquisition I LLC • Biological products, (no disgnostic substances) • California
CUSIP NO. 583916-10-1 13D Page 13 of 13 pages AMENDMENT NO. 1BCC Acquisition I LLC • August 13th, 1998 • Biological products, (no disgnostic substances)
Bay City Capital Management LLC and Bay City Capital LLC By: /s/ Roger H. Salquist --------------------------------------------- Its: ManagerBCC Acquisition I LLC • June 19th, 1998 • Biological products, (no disgnostic substances)
The undersigned hereby agree that any Statement on Schedule 13D to be filed with the Securities and Exchange Commission by any of the undersigned, including any amendment thereto, with respect to securities of Medarex Inc., a New Jersey corporation, may be filed by BCC Acquisition I LLC on behalf of all of the undersigned.
